Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Filed with HKEX · Stock code 6628 · · 10 pages · English
Summary by 6ix AI
The report includes information on authorized and registered share capital, as well as movements in issued shares and treasury shares. It confirms compliance with public float requirements and provides details on share options and other agreements related to share issuance. The filing serves to inform the Hong Kong Exchanges and Clearing Limited about the company's securities activities during the reporting period.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Transcenta Holding Limited on 6ix
Earlier from Transcenta
- Cancellation and grant of award pursuant to the share incentive scheme
- Notification letter and request form to non-registered holders
- Notification letter and reply form to registered holders
- 2026 Interim report
- Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer
Later from Transcenta
- Voluntary announcement-business update on the grant of China invention patents related to osemitamab (TST001) and its companion diagnostic antibody
- Voluntary announcement-receipt of the first payment in relation to the disposal of cdmo assets
Follow Transcenta into a list and get an email when it puts out news.
Follow Transcenta